European Medicines Agency backs AstraZeneca vaccine but blood clot investigation ongoing
Published
Published
The European regulator said it "cannot rule out definitively" a link between the vaccine and very rare cases of blood clotting.
Emer Cooke, European Medicines Agency (EMA) executive director, said there was no indication Oxford/AstraZeneca's coronavirus..